The Global Insulin Infusion Pumps Market is expected to reach USD 7.9 Billion by 2030, at a CAGR of 8.5% during the forecast period 2022 to 2030.
The implantable insulin pump is basically a pump which is implanted surgically under the catheter and skin from the insulin and extended into the peritoneal cavity. The peritoneal cavity consists lots of blood vessels and hence, the absorption of insulin is great in this cavity. These insulin pumps functions on the basis of blood glucose concentration. This means if the blood glucose level is less, the concentration of insulin released is lesser.